0001127602-23-004886.txt : 20230213 0001127602-23-004886.hdr.sgml : 20230213 20230213163910 ACCESSION NUMBER: 0001127602-23-004886 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230213 DATE AS OF CHANGE: 20230213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Flynn Sean C. CENTRAL INDEX KEY: 0001801993 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35280 FILM NUMBER: 23619178 MAIL ADDRESS: STREET 1: C/O VERICEL CORPORATION STREET 2: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vericel Corp CENTRAL INDEX KEY: 0000887359 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943096597 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 7349305555 MAIL ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC DATE OF NAME CHANGE: 19960428 5 1 form5.xml PRIMARY DOCUMENT X0306 5 2022-12-31 0 0 0000887359 Vericel Corp VCEL 0001801993 Flynn Sean C. C/O VERICEL CORPORATION CAMBRIDGE MA 02139 1 SVP, General Counsel Common Stock 2022-03-31 5 A 0 215 32.49 A 3660 D Common Stock 2022-06-30 5 A 0 403 21.40 A 4063 D Common Stock 2022-09-30 5 A 0 25 19.72 A 4088 D Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). /s/ Sean Flynn 2023-02-13